Royalty Pharma prices $2B senior unsecured notes

1 day ago 2

Royalty Pharma (NASDAQ:RPRX) priced an offering of $2B of senior unsecured notes, comprised of, $600M 4.450% notes due 2031, $900M 5.200% notes due 2035; and $500M 5.950% notes due 2055.
The company intends to use the net proceeds from the notes for general